BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24129597)

  • 1. Effect of palonosetron on the QTc interval in patients undergoing sevoflurane anaesthesia.
    Kim HJ; Lee HC; Jung YS; Lee J; Min JJ; Hong DM; Choi EK; Oh S; Jeon Y
    Br J Anaesth; 2014 Mar; 112(3):460-8. PubMed ID: 24129597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of palonosetron for the prevention of postoperative nausea and vomiting: a randomized, double-blinded, placebo-controlled trial.
    Chun HR; Jeon IS; Park SY; Lee SJ; Kang SH; Kim SI
    Br J Anaesth; 2014 Mar; 112(3):485-90. PubMed ID: 24154700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double-blind study.
    Moon YE; Joo J; Kim JE; Lee Y
    Br J Anaesth; 2012 Mar; 108(3):417-22. PubMed ID: 22277663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the acute effect of palonosetron on transmural dispersion of myocardial repolarization.
    Dogan U; Yavas G; Tekinalp M; Yavas C; Ata OY; Ozdemir K
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):462-8. PubMed ID: 22696873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of single doses of IV palonosetron, up to 2.25 mg, on the QTc interval duration: a double-blind, randomized, parallel group study in healthy volunteers.
    Morganroth J; Flaharty KK; Parisi S; Moresino C
    Support Care Cancer; 2016 Feb; 24(2):621-627. PubMed ID: 26111957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic findings of palonosetron in cancer patients.
    Gonullu G; Demircan S; Demirag MK; Erdem D; Yucel I
    Support Care Cancer; 2012 Jul; 20(7):1435-9. PubMed ID: 21773677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of two different interventions for the prevention of postoperative nausea and vomiting: total intravenous anaesthesia using propofol and remifentanil versus prophylactic palonosetron with inhalational anaesthesia using sevoflurane-nitrous oxide.
    Park SK; Cho EJ
    J Int Med Res; 2011; 39(5):1808-15. PubMed ID: 22117981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.
    Singh PM; Borle A; Gouda D; Makkar JK; Arora MK; Trikha A; Sinha A; Goudra B
    J Clin Anesth; 2016 Nov; 34():459-82. PubMed ID: 27687434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period.
    Kovac AL; Eberhart L; Kotarski J; Clerici G; Apfel C;
    Anesth Analg; 2008 Aug; 107(2):439-44. PubMed ID: 18633021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of the Effects of Sevoflurane and Desflurane on Corrected QT Interval Prolongation in Patients Undergoing Living Donor Liver Transplantation: A Prospective Observational Study.
    Min JJ; Lee J; Lee HC; Ryu HG; Shin M; Kim HJ
    Transplant Proc; 2016; 48(1):96-101. PubMed ID: 26915850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized, double-blind, multicenter trial to evaluate the therapeutic efficacy and safety of palonosetron in the treatment of postoperative nausea and vomiting over a 72-h period.
    Hahm TS; Hwang JW; Kim WH; Oh EJ; Kim DK; Choi WJ; Kim YH; Ryu JH; Yoo BH; Yon JH
    J Anesth; 2015 Feb; 29(1):21-8. PubMed ID: 25037960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting.
    Candiotti KA; Kovac AL; Melson TI; Clerici G; Joo Gan T;
    Anesth Analg; 2008 Aug; 107(2):445-51. PubMed ID: 18633022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind trial of palonosetron compared with ondansetron in preventing postoperative nausea and vomiting after gynaecological laparoscopic surgery.
    Park SK; Cho EJ
    J Int Med Res; 2011; 39(2):399-407. PubMed ID: 21672343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Ramosetron and Palonosetron for Preventing Nausea and Vomiting after Spinal Surgery: Association With ABCB1 Polymorphisms.
    Song JW; Shim JK; Choi SH; Soh S; Jang J; Kwak YL
    J Neurosurg Anesthesiol; 2017 Oct; 29(4):406-414. PubMed ID: 27564555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized double blind study to evaluate efficacy of palonosetron with dexamethasone versus palonosetron alone for prevention of postoperative and postdischarge nausea and vomiting in subjects undergoing laparoscopic surgeries with high emetogenic risk.
    Blitz JD; Haile M; Kline R; Franco L; Didehvar S; Pachter HL; Newman E; Bekker A
    Am J Ther; 2012 Sep; 19(5):324-9. PubMed ID: 21519222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous palonosetron increases the incidence of QTc prolongation during sevoflurane general anesthesia for laparotomy.
    Min JJ; Yoo Y; Kim TK; Lee JM
    Korean J Anesthesiol; 2013 Nov; 65(5):397-402. PubMed ID: 24363841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of single-breath vital capacity rapid inhalation with sevoflurane 5% and propofol induction on QT interval and haemodynamics for laparoscopic surgery.
    Sen S; Ozmert G; Boran N; Turan H; Caliskan E
    Eur J Anaesthesiol; 2004 Jul; 21(7):543-6. PubMed ID: 15318466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of palonosetron with palonosetron-dexamethasone combination for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
    Bala I; Bharti N; Murugesan S; Gupta R
    Minerva Anestesiol; 2014 Jul; 80(7):779-84. PubMed ID: 24280811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ramosetron on QTc interval: a randomised controlled trial in patients undergoing off-pump coronary artery bypass surgery.
    Kim TK; Cho YJ; Lim CW; Min JJ; Choi EK; Hong DM; Jeon Y
    BMC Anesthesiol; 2016 Aug; 16(1):56. PubMed ID: 27488394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB
    Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.